Last reviewed · How we verify
Short-term preoperative treatment of primary hyperaldosteronism
Approved treatments
- Aldactone · Pfizer Inc.
Aldosterone antagonist causing increased sodium and water excretion while retaining potassium.
Clinical guidelines
- FDA label — 1L
Spironolactone is indicated for short-term preoperative treatment of primary hyperaldosteronism.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Short-term preoperative treatment of primary hyperaldosteronism patent landscape — cliff calendar, originator estates, attackable patents
- Short-term preoperative treatment of primary hyperaldosteronism treatment landscape brief
- Short-term preoperative treatment of primary hyperaldosteronism treatment updates RSS
Frequently asked questions about Short-term preoperative treatment of primary hyperaldosteronism
What drugs treat Short-term preoperative treatment of primary hyperaldosteronism?
Tracked treatments include Aldactone.
What is the treatment for Short-term preoperative treatment of primary hyperaldosteronism?
Standard treatment for Short-term preoperative treatment of primary hyperaldosteronism includes Aldactone. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Short-term preoperative treatment of primary hyperaldosteronism?
FDA label publishes guidelines for Short-term preoperative treatment of primary hyperaldosteronism. 1 guideline references tracked.
Related
- Treatment landscape: Short-term preoperative treatment of primary hyperaldosteronism patent cliff · Short-term preoperative treatment of primary hyperaldosteronism CI report
- Treatment: Aldactone · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing